ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

NCI To Seek Cancer Act Changes On Center Grant Limits

April 9, 1976

NCI Plans 3 Percent Across-The-Board Cut To Pool Funds For High Priorities In FY08.

September 21, 2007

NCI Grants Awarded To Develop Special Populations Networks. AACR Honors Feinstein, Khayat.

April 7, 2000

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

In Brief: NCI Cutting Back Support For Training Medical, Pediatric Oncologists; Clark Receives ACS Award

December 5, 1980

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002